Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cornea ; 30(9): 1054-7, 2011 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-21673567

RESUMO

PURPOSE: To report a case of recurrent corneal graft failure because of cytomegalovirus (CMV) infection and to demonstrate successful clearance of the virus with oral valganciclovir, confirmed by polymerase chain reaction (PCR) assay. This allowed for a successful corneal autograft to be performed. METHODS: Interventional case report. RESULTS: A 90-year-old white man with 4 previous corneal graft failures in his right eye is presented. His visual acuity was no light perception in the left eye subsequent to ocular trauma. His initial penetrating keratoplasty for pseudophakic bullous keratopathy was from a human leukocyte antigen-matched multiorgan donor who was CMV-seropositive. An anterior chamber paracentesis was performed to exclude an infective etiology. CMV was detected on PCR of aqueous humor. After a 12-week course of oral valganciclovir, a repeat aqueous PCR test confirmed the clearance of CMV. A corneal autograft from his left eye was subsequently performed with good outcome. CONCLUSIONS: We present a case of successful corneal autograft after clearance of CMV from the anterior chamber (PCR confirmed) in a patient treated with oral valganciclovir.


Assuntos
Antivirais/uso terapêutico , Humor Aquoso/virologia , Infecções por Citomegalovirus/cirurgia , Infecções Oculares Virais/cirurgia , Ganciclovir/análogos & derivados , Ceratoplastia Penetrante , Administração Oral , Idoso de 80 Anos ou mais , Citomegalovirus/genética , Citomegalovirus/isolamento & purificação , Infecções por Citomegalovirus/tratamento farmacológico , Infecções por Citomegalovirus/virologia , DNA Viral/análise , Infecções Oculares Virais/tratamento farmacológico , Infecções Oculares Virais/virologia , Ganciclovir/uso terapêutico , Rejeição de Enxerto/cirurgia , Sobrevivência de Enxerto , Humanos , Masculino , Reação em Cadeia da Polimerase , Recidiva , Reoperação , Transplante Autólogo , Transplante Homólogo , Valganciclovir
2.
Clin Exp Ophthalmol ; 33(1): 41-6, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15670077

RESUMO

AIM: To assess the incidence and risk factors for Acanthamoeba keratitis (AK), the diagnostic interval, and the efficacy and outcome of current treatment among the population of New South Wales, Australia. METHODS: A retrospective review was carried out of all cases of AK treated at the Sydney Eye Hospital between January 1997 and December 2002. RESULTS: Twenty patients were identified with a mean follow up of 24.8 +/- 21.5 months. Acanthamoeba keratitis constitutes 4.7% of severe infective keratitis treated at Sydney Eye Hospital. The mean interval from first presentation to diagnosis was 26.6 +/- 35.1 days overall; 17.2 +/- 33.1 days for those presenting directly to our unit (69% being diagnosed within 72 h of presentation), and 44.1 +/- 34.0 days for those first presenting elsewhere. Of those with a diagnostic delay >1 month, 57% had been mistakenly diagnosed with Herpes simplex keratitis. Sixteen (80%) wore contact lenses, and eight (40%) had additional risk factors including poor lens hygiene. Complications occurred in 16 (80%), with seven (35%) requiring surgical intervention. Visual acuity improved in 18 (90%), worsened in two patients (10%), and 75% achieved 6/12 or better at last follow up. CONCLUSIONS: Acanthamoeba keratitis is a rare infection, and contact lens wear remains the commonest association, with poor hygiene constituting significant additional risk. The visual outcome has improved with the availability of effective amoebicidal agents, but patients with a diagnostic delay and non-contact lens wearers are at increased risk of recurrent disease. A high index of clinical suspicion remains the most effective strategy in implementing early treatment, and enabling a favourable outcome.


Assuntos
Ceratite por Acanthamoeba/epidemiologia , Ceratite por Acanthamoeba/diagnóstico , Ceratite por Acanthamoeba/tratamento farmacológico , Adolescente , Adulto , Idoso , Antiprotozoários/uso terapêutico , Lentes de Contato/parasitologia , Lentes de Contato/estatística & dados numéricos , Córnea/parasitologia , Feminino , Seguimentos , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , New South Wales/epidemiologia , Estudos Retrospectivos , Fatores de Risco , Resultado do Tratamento , Acuidade Visual
3.
Cornea ; 22(7): 612-8, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-14508257

RESUMO

PURPOSE: To evaluate the efficacy and safety of lamellar keratoplasty (LK) in the treatment of recurrent pterygium and of scleral necrosis induced by beta-irradiation. METHODS: A retrospective review of patients who, between 1988 and 2001, underwent LK for the above indications. Recurrence rates, tectonic outcomes, pre- and postoperative visual acuities, and complications were analyzed. RESULTS: In the recurrent pterygium group, LK was performed on 68 eyes. The mean age (mean +/- SD) at presentation was 45.1 +/- 13.7 years (range 17 to 77). The recurrence rate following LK was 5.9%, with a mean time to recurrence of 6.2 +/- 2.9 months (range 3 to 10). In all cases, the recurrence occurred above or below the lamellar grafts, and a second LK prevented any further recurrence. The mean length of follow-up was 27.1 +/- 26.6 months (range 3 to 132). The best-corrected visual acuity (BCVA) improved or remained unchanged in 65 of the 68 eyes (95.6%) but was reduced in the remaining three eyes (4.4%). In the scleral radionecrosis group, LK was performed on 30 eyes. The mean age at presentation was 67.7 +/- 10.3 years (range 37 to 85). Tectonic restoration was achieved in all patients. The mean length of follow-up was 49.0 +/- 45.1 months (range 8 to 120). The BCVA improved or remained unchanged in all patients. No significant complications were identified. CONCLUSION: Lamellar keratoplasty is a safe and effective treatment option for both recurrent pterygium and beta-irradiation-induced scleral necrosis. In our opinion, LK is the treatment of choice for multiple or aggressive recurrences of pterygium and a successful management option for scleral radionecrosis.


Assuntos
Partículas beta/efeitos adversos , Transplante de Córnea , Pterígio/cirurgia , Lesões por Radiação/complicações , Doenças da Esclera/etiologia , Doenças da Esclera/cirurgia , Adolescente , Adulto , Idoso , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Necrose , Recidiva , Doenças da Esclera/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...